(Q37762274)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Lisa M Ebert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Ashley Knights

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Heather Jackson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Weisan Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

617-629

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

4 February 2020

cites work

1 reference

Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens

21 January 2018

1 reference

Cancer/testis antigens, gametogenesis and cancer

21 January 2018

1 reference

Genome-wide analysis of cancer/testis gene expression

21 January 2018

1 reference

Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.

21 January 2018

1 reference

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

21 January 2018

1 reference

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

21 January 2018

1 reference

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

21 January 2018

1 reference

Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses.

21 January 2018

1 reference

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.

21 January 2018

1 reference

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1

21 January 2018

1 reference

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

21 January 2018

1 reference

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

21 January 2018

1 reference

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

21 January 2018

1 reference

Seromic profiling of ovarian and pancreatic cancer

21 January 2018

1 reference

Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.

21 January 2018

1 reference

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

21 January 2018

1 reference

Human tumor-specific T lymphocytes: does function matter more than number?

21 January 2018

1 reference

Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients

21 January 2018

1 reference

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

21 January 2018

1 reference

NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.

21 January 2018

1 reference

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells

21 January 2018

1 reference

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

21 January 2018

1 reference

Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T-lymphocytes in vitro.

21 January 2018

1 reference

Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA

21 January 2018

1 reference

Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells.

21 January 2018

1 reference

Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy

21 January 2018

1 reference

Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

21 January 2018

1 reference

Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals

21 January 2018

1 reference

Post-translational modifications of naturally processed MHC-binding epitopes

21 January 2018

1 reference

Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules

21 January 2018

1 reference

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

21 January 2018

1 reference

A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design

21 January 2018

1 reference

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid

21 January 2018

1 reference

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

21 January 2018

1 reference

The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length

21 January 2018

1 reference

Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants

21 January 2018

1 reference

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

21 January 2018

1 reference

Regulatory T cells and immune tolerance

21 January 2018

1 reference

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

Positive and negative influences of regulatory T cells on tumour immunity.

21 January 2018

1 reference

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

Tumor-specific regulatory T cells in cancer patients

21 January 2018

1 reference

Regulating the immune response to tumours

21 January 2018

1 reference

The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.

21 January 2018

1 reference

Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma

21 January 2018

1 reference

Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.

21 January 2018

1 reference

Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation

21 January 2018

1 reference

Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma

21 January 2018

1 reference

Therapeutic vaccines in solid tumours: can they be harmful?

21 January 2018

1 reference

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

21 January 2018

1 reference

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

21 January 2018

1 reference

Combining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cells.

21 January 2018

1 reference

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity

21 January 2018

1 reference

Plumbing the sources of endogenous MHC class I peptide ligands

21 January 2018

1 reference

Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

21 January 2018

1 reference

Bystander elimination of antigen loss variants in established tumors

21 January 2018

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection

21 January 2018

1 reference

"MIATA"-minimal information about T cell assays

21 January 2018

1 reference

A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518717%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference